BlackLight has formed a wholly-owned subsidiary company, Millsian, Inc., dedicated to developing the molecular modeling applications of classical physics (CP), solving atomic and molecular structures based on applying the classical laws of physics, (Newton's and Maxwell's Laws) to the atomic scale. The set of individual bonds between two atoms apiece of a molecule are known as the functional groups. The functional groups (Table 1) of essentially all major classes of chemical bonding including those involved in most organic molecules have been solved in analytical form. By using these functional groups as building blocks, or independent units, a potentially infinite number of molecules can be solved. As a result, Millsian software can visualize the exact three-dimensional physical structure, calculate physical characteristics of a boundless number of molecules of any length and complexity, and facilitate the engineering of new pharmaceuticals and materials at the molecular level. The results obtained in real-time match the experimental values typically to the limit of measurement.

Even complex proteins and DNA (the molecules that encode genetic information) can be solved in real-time interactively on a personal computer. By contrast, previous software based on traditional quantum methods must resort to approximations run on powerful computers for even the simplest systems. The Company believes that Millsian software represents a major breakthrough that may impact nearly all businesses involved in drug development, material science, and chemistry. Millsian plans to license its molecular modeling tool for use by a variety of industries including pharmaceutical, semiconductor, chemical, agricultural, nanotech, and any industry with products and businesses that will benefit from this improvement in molecular modeling. The Millsian competitive advantage includes rendering true molecular structures providing precise bonding characteristics, spatial and temporal charge distributions, and energies of every electron in every bond and bonding atom, facilitating the identification of biologically active sites in drugs; and, facilitating drug design. The Millsian 2.0 Beta software has recently been released, and will be initially marketed to the academic and pharmaceutical markets.

Additional types of bonding such as the ionic bond, the metallic bond, condensed matter materials, and additional major fields of chemistry given in Table 2 have been solved classically. The exact classical bonding solutions and the extension of the predictive capability as molecular predictions made by Millsian technology constitute conclusive evidence of the correctness of classical physics applied to atoms and molecules.